Navigation Links
ICBU Announces Corporate Reorganization and Business Plan

TAMPA, Fla., Feb. 8, 2011 /PRNewswire/ -- In the Third Quarter of 2010, The Board of Directors of International Coastal Biofuels (OTC MARKETS: ICBU) has elected to change the company name to iMD Companies, Inc. In addition, a new management team will take control of ICBU with the objective of propelling the company into the health and wellness arena.  The new management has opted to alter the basic structure of the firm to that of a holding company.  The new structure has the company looking for promising acquisitions in the healthcare industry and other related fields.  Saeb Jannoun has been elected Chairman of the Board of Directors as well as Chief Executive Officer.  Bruce Collett has been named Vice President and to the Board of Directors.

iMD's management will be led by serial entrepreneurs who intend to make iMD a serious player in their target areas. Management's purpose moving forward is to acquire, develop and group, promising entities under one roof, providing them with the collective power afforded by their joint assets and economies of scale.  This strategy will prove to be a profitable and financially sound platform for iMD's success.

As a first step, iMD has completed the acquisition of Integrated Medical Diagnostics, Inc.  Integrated has been performing ultrasound image analysis for over eight years using a proprietary measurement and reporting system. The company has been producing solid revenues for several years. Using a skilled team of technicians, Integrated has developed the PCI Heartscan report.  This proprietary report measures arterial lining thickness as well as arterial plaque, providing health care practitioners with a useful tool in the early detection of cardiovascular disease.

As a plus, Integrated has continued to compile a database using several statistical markers from the over 40,000 studies it has conducted.  This growing database will prove to be of great value when key data is extracted, not to mention the market value of the data itself.

The company's reorganization was approved by the Financial Industry Regulatory Association (FINRA) effective October 12, 2010.  The company was then approved and cleared the underwriting requirements under the Depository Trust & Clearing Corporation (DTCC) effective October 22, 2010.

The company has now been upgraded to fully compliant on the OTC Markets, Pinksheets Quotation Service.  "New management plans to announce its physical 2011 aggressive growth and expansion plans shortly" stated Jannoun. "We plan to state our goals clearly and concisely, and lay out a specific road map on how we plan to accomplish each and every goal, using the newest and most innovative marketing strategies created in the marketplace in the recent years. Our focus will always be on growth internally and increasing shareholder value externally," Jannoun concluded.


IMD Companies, Inc., (OTC MARKETS:ICBU) is a Florida corporation, engaged in the medical diagnostics and health and fitness industries. Its primary products and services lie in the health and fitness nutraceutical and medical diagnostics services markets. The company further plans to expand into the weight-loss industry. The company delivers its medical diagnostic services on-site participating medical clinics and physician offices. The nutraceutical supplements, pills, bar and gels will be marketed and distributed through participating clinics and on-line web marketing retail methods.  The company will continue to develop its innovative marketing strategies, including the use of social networking vehicles.

Safe Harbor Statement:

Certain statements made in this press release constitute forward-looking statements that are based on management's expectations, estimates, projections and assumptions. Words such as "expects," "anticipates," "plans," "believes," "scheduled," "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors. All forward-looking statements speak only as of the date of this press release and the company does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.

SOURCE IMD Companies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeant Pharmaceuticals Announces License Of ACZONE® (dapsone) Gel 5% In Canada
2. 2P2D Ltd. Announces the Appointment of Tovi Bachar, Former Managing Director of GE Healthcare Israel, as Director and Chairman
3. BD Announces Results For 2011 First Fiscal Quarter
4. Sangamo BioSciences Announces Presentation at the 13th Annual BIO CEO & Investor Conference
5. BD Announces Agreement to Acquire Accuri Cytometers, Inc.
6. Misonix Announces Completion of Product Registrations in Key Latin American Markets
7. ConvaTec Announces New Appointments to Leadership Team
8. Medivation Announces Participation in 13th Annual BIO CEO & Investor Conference
9. Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements
10. Fairleigh Dickinson University Announces Partnership with Medco Health Solutions, Inc. for New School of Pharmacy
11. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2010 Financial Results
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American ... function testing company, is now able to perform sophisticated lung assessments ... ndd Medical Technologies , Inc. Patients are no ...  Thanks to ndd,s EasyOne PRO ® , ARL patients like Jeanne ... needed testing done in the comfort of her own home. ...
Breaking Medicine Technology:
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
Breaking Medicine News(10 mins):